There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria (CSU) drug into phase 2, instead preparing ...

Patients with chronic spontaneous urticaria experienced a long delay in diagnosis, a substantial impact on their quality of life, and often received inadequate treatment, highlighting the need for ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody placulumab, and positive results from the phase 3 studies of remibrutinib.

Urticaria or hives is a skin condition causing itchy red welts from various triggers Read ahead know its symptoms and why it ...

Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...

The following is a summary of “Dupilumab Improves Urticaria-Specific Quality of Life in Patients with Chronic Spontaneous ...